The 2025 Psychedelic Science Conference in Denver, explores the therapeutic benefits of psychedelics.
Breakdown
- Colorado hosts the MAPS conference, spotlighting decriminalized natural psychedelics. 4s
- Industry leaders and companies promote therapeutic uses of substances like ibogaine and psilocybin. 1m 25s
- Ibogaine remains illegal in the U.S., but research and legislative interest are growing. 1m 59s
- Ketamine is the only psychedelic currently approved for therapeutic use in the U.S. 2m 59s
- California and Texas are advancing legislation to expand psychedelic research and access. 3m 59s